Richard Rosen, MD and Belinda Shirkey, MD
To compare visual acuity outcome among 3 groups of participants: those who are randomly assigned to receive standard care and those randomly assigned to receive one of two doses of intravitreal injection(s) of triamcinolone acetonide for treatment of macular edema associated with central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO).
Study results are currently being analyzed. Please visit this webpage next month for the study update.
For more information: